Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma

International Journal of Clinical Oncology

Volumn 18, Issue 4, 2013, Pages 651-656

  Tovuu, Lkhagva Ochir ^a   Imura, Satoru ^a   Utsunomiya, Tohru ^a   Morine, Yuji ^a   Ikemoto, Tetsuya ^a   Arakawa, Yusuke ^a   Mori, Hiroki ^a   Hanaoka, Jun ^a   Kanamoto, Mami ^a   Sugimoto, Koji ^a   Iwahashi, Shuichi ^a   Saito, Yu ^a   Yamada, Shinichiro ^a   Asanoma, Michihito ^a   Miyake, Hidenori ^a   Shimada, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CD44; Hepatocellular carcinoma; Non tumor tissue; Prognostic factor

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; HERMES ANTIGEN;

AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; HEPATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION;

AGED; ANTIGENS, CD44; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

EID: 84882616683     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0432-6     Document Type: Article

References (25)

1. Llovet JM, Beaugrand M (2003) Hepatocellular carcinoma: present status and future prospects. J Hepatol 38:S136-S149
2. Bruix J, Boix L, Sala M et al (2004) Focus on hepatocellular carcinoma. Cancer Cell 5:215-219
3. Lee JG, Kang CM, Park JS et al (2006) The actual five-year survival rate of hepatocellular carcinoma patients after curative resection. Yonsei Med J 47:105-112
4. Bendall LJ, Nillson SK, Khan NI et al (2004) Role of CD44 variant exon 6 in acute lymphoblastic leukemia: association with altered bone marrow localization and increased tumour burden. Leukemia 18:1308-1311
5. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol 4:33-45
6. Cooper DL, Dougherty GJ (1995) To metastasize or not? Selection of CD44 splice sites. Nat Med 1:635-637
7. Liu J, Jiang G (2006) CD44 and hematologic malignancies. Cell Mol Immunol 3:359-365
8. Naor D, Nedvetzki S, Golan I et al (2002) CD44 in cancer. Crit Rev Clin Lab Sci 39:527-579
9. Jin L, Hope K, Zhai Q et al (2006) Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12:1167-1174
10. Leung EL, Fiscus RR, Tung JW et al (2010) Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS ONE 5:e14062
11. + population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15(10):2927-2933
12. Jothy S (2003) CD44 and its partners in metastasis. Clin Exp Metastasis 20:195-201
13. Seiter S, Schadendorf D, Herrmann K et al (1996) Expression of CD44 variant isoforms in malignant melanoma. Clin Cancer Res 2:447-456
14. Akisik E, Bavbek S, Dalay N (2002) CD44 variant exons in leukemia and lymphoma. Pathol Oncol Res 8:36-40
15. Endo K, Terada T (2000) Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol 32:78-84
16. Iizuka N, Oka M, Yamada-Okabe H et al (2003) Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361:923-929
17. Wang SM, Ooi LL, Hui KM (2007) Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma. Clin Cancer Res 13:6275-6283
18. Woo HG, Park ES, Cheon JH et al (2008) Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res 14:2056-2064
19. Poon RT, Fan ST, Ng IO et al (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500-507
20. Kumada T, Nakano S, Takeda I et al (1997) Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25:87-92
21. Utsunomiya T, Okamoto M, Wakiyama S et al (2006) Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients. Ann Surg Oncol 13:947-954
22. Utsunomiya T, Shimada M, Imura S et al (2010) Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol 45:146-152
23. Kim HR, Wheeler MA, Wilson CM et al (2004) Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res 64(13):4569-4576
24. Zöller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11(4):254-267
25. Marhaba R, Klingbeil P, Nuebel T et al (2008) CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8(8):784-804